Portal do Butantan

Butantan and Sandoz begin technology transfer with the delivery of 400,000 units of medicine for rheumatoid arthritis to the Brazilian Unified Health System (SUS)

The drug adalimumab will be produced entirely in Brazil and will benefit 30,000 people per year


Publicado em: 23/11/2022

Editable text here, click here to fill out
Editable text here, click here to fill out